WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
US Stock Market Move | Many popular Chinese concept stocks have risen, with Li Auto, Inc. Sponsored ADR Class A (LI.US) up more than 3%.
US Stock Market Move | Deutsche Bank Aktiengesellschaft (DB.US) falls nearly 3% as employees are raided and searched in money laundering investigation.
US Stock Market Move | Starbucks Corporation (SBUX.US) rose by more than 4%, with both the North American and Chinese markets showing signs of recovery. Same-store sales have increased for two consecutive quarters.
US Stock Market Move | Many popular Chinese concept stocks have risen, with Li Auto, Inc. Sponsored ADR Class A (LI.US) up more than 3%.
US Stock Market Move | Deutsche Bank Aktiengesellschaft (DB.US) falls nearly 3% as employees are raided and searched in money laundering investigation.
US Stock Market Move | Starbucks Corporation (SBUX.US) rose by more than 4%, with both the North American and Chinese markets showing signs of recovery. Same-store sales have increased for two consecutive quarters.
RECOMMEND
New Record Achieved As Spot Gold Tops $5,000 For The First Time; Institutions Set $6,600 Target
27/01/2026
117 Companies Raised Over HKD 285.6 Billion Through IPOs As Hong Kong Reclaims Global Leadership In 2025
27/01/2026
“A+H Hong Kong Listing Requires RMB 30 Billion Market Cap”? On‑Site Inquiry Dispels The Rumor
27/01/2026
